Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Willis Towers Watson logoWillis Towers Watson WTW

Willis Towers Watson said revenue for the 3 months ended September 30, 2025 was $2.3 billion, the same as the prior-year period, and decreased $1 million on an as-reported basis, while organic revenue growth, adjusting for the impacts of foreign currency and acquisitions and disposals, was 5%.

10-QQuarterly reportFiled Period of report Summary published (UTC)

Key points

AI summary
  1. Willis Towers Watson said revenue for the 3 months ended September 30, 2025 was $2.3 billion, the same as the prior-year period, and decreased $1 million on an as-reported basis, while organic revenue growth, adjusting for the impacts of foreign currency and acquisitions and disposals, was 5%.

  2. The company said the decrease in as-reported revenue was due primarily to the sale of its TRANZACT business on December 31, 2024. Currency translation increased revenue by $32 million for the 3 months and $26 million for the 9 months.

  3. Willis Towers Watson said HWC segment operating income for the 3 months was $361 million, compared to $329 million in the prior year, and R&B segment operating income was $189 million, compared to $170 million in the prior year. The company cited operating efficiencies as a factor in the increases for both segments.

  4. The company said adjusted operating income for the 3 months was $467 million, compared to $414 million in the prior year, and adjusted EBITDA was $515 million, compared to $479 million in the prior year. Willis Towers Watson cited lower marketing expenses as a factor in the increases.

Key figures

Quarter ended September 30, 2025

Revenue
$2.2B
Operating income
$418M
Net income
$304M
EPS
$3.11

From the XBRL financial data filed with the SEC · not processed by AI.

Summary

AI-written

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

Quarterly Revenue $2.3 billion, Organic Growth 5%

Willis Towers Watson said revenue for the 3 months ended September 30, 2025 was $2.3 billion, the same as the prior-year period, and decreased $1 million on an as-reported basis, while organic revenue growth, adjusting for the impacts of foreign currency and acquisitions and disposals, was 5%.

Source · Based on the MD&A text of the filing

TRANZACT Sale and Currency Effects

The company said the decrease in as-reported revenue was due primarily to the sale of its TRANZACT business on December 31, 2024. Currency translation increased revenue by $32 million for the 3 months and $26 million for the 9 months.

Source · Based on the MD&A text of the filing

Segment Quarterly Operating Income

Willis Towers Watson said HWC segment operating income for the 3 months was $361 million, compared to $329 million in the prior year, and R&B segment operating income was $189 million, compared to $170 million in the prior year. The company cited operating efficiencies as a factor in the increases for both segments.

Source · Based on the MD&A text of the filing

Adjusted Operating Income and Adjusted EBITDA

The company said adjusted operating income for the 3 months was $467 million, compared to $414 million in the prior year, and adjusted EBITDA was $515 million, compared to $479 million in the prior year. Willis Towers Watson cited lower marketing expenses as a factor in the increases.

Source · Based on the MD&A text of the filing

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.